Related references
Note: Only part of the references are listed.Transgenic Overexpression of 14-3-3 Zeta Protects Hippocampus against Endoplasmic Reticulum Stress and Status Epilepticus In Vivo
Gary P. Brennan et al.
PLOS ONE (2013)
A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of A on synapses and dendritic spines
Wendou Yu et al.
HUMAN MOLECULAR GENETICS (2012)
Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency
P-S Cheah et al.
MOLECULAR PSYCHIATRY (2012)
Properties of the Monomeric Form of Human 14-3-3ζ Protein and Its Interaction with Tau and HspB6
Nikolai N. Sluchanko et al.
BIOCHEMISTRY (2011)
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Hamid Y. Qureshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain
Yifan Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Microtubule-Disrupting Chemotherapeutics Result in Enhanced Proteasome-Mediated Degradation and Disappearance of Tubulin in Neural Cells
Lyn M. Huff et al.
CANCER RESEARCH (2010)
Tau Ser262 phosphorylation is critical for Aβ42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease
Koichi Iijima et al.
HUMAN MOLECULAR GENETICS (2010)
Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding
Chad J. Leugers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
N-cadherin mediates plasticity-induced long-term spine stabilization
Pablo Mendez et al.
JOURNAL OF CELL BIOLOGY (2010)
14-3-3τ Regulates Ubiquitin-Independent Proteasomal Degradation of p21, a Novel Mechanism of p21 Downregulation in Breast Cancer
Bing Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The 14-3-3ζ Protein Binds to the Cell Adhesion Molecule L1, Promotes L1 Phosphorylation by CKII and Influences L1-Dependent Neurite Outgrowth
Elisa M. Ramser et al.
PLOS ONE (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro
Dong Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation
Golam Sadik et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells
Wei Song et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Kurt R. Brunden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth
Ralf S. Schmid et al.
CURRENT OPINION IN NEUROBIOLOGY (2008)
Up-regulation of 14-3-3ζ in lung cancer and its implication as prognostic and therapeutic target
Tao Fan et al.
CANCER RESEARCH (2007)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Effects of tau phosphorylation on proteasome activity
Qing-Guo Ren et al.
FEBS LETTERS (2007)
Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation
Tong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Glycogen synthase kinase 3β phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism
T Li et al.
BIOCHEMISTRY (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells
TM Vinogradova et al.
CIRCULATION RESEARCH (2006)
14-3-3 proteins as potential oncogenes
Guri Tzivion et al.
SEMINARS IN CANCER BIOLOGY (2006)
Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39
F Sakaue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
14-3-3σ expression 9s an independent prognostic parameter for poor survival in colorectal carcinoma patients
A Perathoner et al.
CLINICAL CANCER RESEARCH (2005)
Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues
WQ Qi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila
I Nishimura et al.
CELL (2004)
Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers
F Hernández et al.
NEUROSCIENCE LETTERS (2004)
Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains
Y Kawamoto et al.
ACTA NEUROPATHOLOGICA (2004)
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations
AD Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The 14-3-3 protein ε isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes
J Satoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration:: involvement of 14-3-3 zeta in this dynamic process
C Soulié et al.
NEUROSCIENCE LETTERS (2004)
Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain
SJ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease
T Umahara et al.
ACTA NEUROPATHOLOGICA (2004)
Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals
WG Honer
NEUROBIOLOGY OF AGING (2003)
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
JC Cruz et al.
NEURON (2003)
14-3-3 proteins in the nervous system
D Berg et al.
NATURE REVIEWS NEUROSCIENCE (2003)
14-3-3γ is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes
XQ Chen et al.
GLIA (2003)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis
P Delobel et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo
PS Amieux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Glycogen synthase kinase-3,β is complexed with tau protein in brain microtubules
W Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of synaptophysin degradation by mammalian homologues of Seven in Absentia
TC Wheeler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons
L Tarsa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure
M von Bergen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain
F Lim et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1
T Harada et al.
NATURE CELL BIOLOGY (2001)
Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
JJ Lucas et al.
EMBO JOURNAL (2001)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord
A Malaspina et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells
V Vogelsberg-Ragaglia et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling
JM Angelastro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
14-3-3ζ is an effector of tau protein phosphorylation
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Properties of NACP/α-synuclein and its role in Alzheimer's disease
A Iwai
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau
K Sobue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
MK Ahlijanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)